Chelsea and Westminster Hospital NHS Foundation Trust

The Chelsea and Westminster Hospital NHS Foundation Trust incorporates Chelsea & Westminster Hospital in London http://www.chelwest.nhs.uk/

In 2014, West Middlesex University Hospital NHS Trust merged into Chelsea and Westminster Hospital NHS Foundation Trust.

View previous outcomes

View Trust Services

This trust offers the following services:

  • Acute services:
    • On-site bowel stenting facilities
  • Surgical services:
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
    • Dedicated Specialist Advanced Outpatient Clinic
    • Distal sacrectomy
  • Diagnostic and pre-operative services:
    • Routine Genetic Testing for Lynch Syndrome
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • 7-day access to face-to-face palliative care services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 239 1558 35779
Case ascertainment (%) Good Fair Good
Data completeness of:
– Pre-treatment TNM (%) 76 81 86
– Performance status (%) 70 78 89
Patients having major resection: Trust Network National
Number of patients in Audit 128 848 19631
ASA grade 1 (%) 9 22 9
ASA grade 2 (%) 47 52 53
ASA grade 3 (%) 32 21 31
ASA grade 4+ (%) 2 1 2
ASA grade not recorded (%) 10 4 4
Data completeness of:
7 Audit items for risk-adjustment (%) 84 93 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 239 1558 35779
Seen by Clinical Nurse Specialist (%) 94 85 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 128 848 19614
Distant metastases (%) 5 6 5
Urgent or emergency surgery (%) 13 10 15
At least 12 lymph nodes excised (%) 96 93 84
Laparoscopic surgery attempted (%) 88 63 72
Risk-adjusted length of stay > 5 days (%) 79 74 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 81 N/A 10747
Adjuvant chemotherapy (%) 63 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 12 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) N/A N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 30 N/A 4251
Neoadjuvant therapy (%) 23 N/A 33
Circumferential resection margin: Recorded (%) 100 98 89
Circumferential resection margin: Negative (%) 100 94 83
Rectal volume 30 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 114 985 19644
APER/Hartmanns (%) 17 31 37

Compare trust outcomes